These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 14766244

  • 1. cis-Diamminedichloroplatinum-resistant cell lines derived from human epithelial ovarian carcinoma express increased susceptibility to angiogenesis inhibitor TNP-470.
    Tamura M, Takakuwa K, Tanaka K.
    Gynecol Oncol; 2004 Feb; 92(2):530-6. PubMed ID: 14766244
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.
    Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K.
    Cancer Res; 1993 Jun 01; 53(11):2566-70. PubMed ID: 7684319
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
    Kudoh K, Kikuchi Y, Hiramatsu H, Hirata J, Yamamoto K, Kita T, Nagata I.
    Eur J Cancer; 1997 Jan 01; 33(1):122-8. PubMed ID: 9071911
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells.
    Kikuchi Y, Hirata J, Kita T, Imaizumi E, Tode T, Nagata I.
    Gynecol Oncol; 1993 Jun 01; 49(3):365-72. PubMed ID: 8314539
    [Abstract] [Full Text] [Related]

  • 5. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T.
    Int J Gynecol Cancer; 2012 Jul 01; 22(6):922-9. PubMed ID: 22672985
    [Abstract] [Full Text] [Related]

  • 6. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
    Kikuchi Y, Iwano I, Miyauchi M, Kita T, Sugita M, Tenjin Y, Nagata I.
    Jpn J Cancer Res; 1990 Jul 01; 81(6-7):701-6. PubMed ID: 2119370
    [Abstract] [Full Text] [Related]

  • 7. [Experimental therapy with angiogenesis inhibitor TNP-470 on human ovarian cancer transplanted subcutaniously in nude mice].
    Kong H, Jin Z, Yao M.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep 01; 37(9):556-8. PubMed ID: 12411020
    [Abstract] [Full Text] [Related]

  • 8. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991 Mar 15; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

  • 10. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
    Hirata J, Kikuchi Y, Kita T, Imaizumi E, Tode T, Ishii K, Kudoh K, Nagata I.
    Int J Cancer; 1993 Sep 30; 55(3):521-7. PubMed ID: 8375936
    [Abstract] [Full Text] [Related]

  • 11. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II).
    Kikuchi Y, Hirata J, Hisano A, Tode T, Kita T, Nagata I.
    Gynecol Oncol; 1995 Jul 30; 58(1):11-5. PubMed ID: 7789875
    [Abstract] [Full Text] [Related]

  • 12. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J, Haisa M, Naomoto Y, Takaoka M, Kimura M, Yamatsuji T, Notohara K, Tanaka N.
    Jpn J Cancer Res; 2000 Jun 30; 91(6):643-50. PubMed ID: 10874218
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T, Yasoshima T, Denno R, Mukaiya M, Sato N, Hirata K.
    Jpn J Cancer Res; 1998 Sep 30; 89(9):963-9. PubMed ID: 9818033
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M, Ishiguro M, Iwasaki H, Kikuchi M, Kawarabayashi T.
    Gynecol Oncol; 2003 Apr 30; 89(1):88-94. PubMed ID: 12694659
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N, Adachi S, Misawa Y, Yuzawa H, Honda T, Kanazawa K, Takeuchi S Tanaka K, Tanaka K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan 30; 41(1):7-14. PubMed ID: 2647872
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
    Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P.
    J Transl Med; 2008 Feb 26; 6():9. PubMed ID: 18302761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.